Biontech
BioNTech SE, headquartered in Mainz, Germany, is a leading player in the Research and Development sector of biotechnology, excluding nanobiotechnology. Founded in 2008, the company has made significant strides in mRNA technology, particularly in the development of innovative therapies and vaccines for infectious diseases and cancer.
With a strong focus on personalised medicine, BioNTech's core products include its groundbreaking mRNA-based vaccines, which gained global recognition during the COVID-19 pandemic. The company has established itself as a pioneer in the biotechnology field, achieving notable milestones such as the rapid development of its COVID-19 vaccine in collaboration with Pfizer.
BioNTech's commitment to advancing healthcare solutions positions it as a formidable entity in the biotechnology landscape, with a robust pipeline of therapeutic candidates aimed at addressing unmet medical needs.
+20 vs industry average
Biontech’s score of 45 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Biontech?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research and Development in Biotechnology (except Nanobiotechnology) has typical carbon intensity
Industry performance
The Research and Development in Biotechnology (except Nanobiotechnology) industry has reduced its overall emissions by 19% since 2018
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Biontech's reported carbon emissions
BioNTech, a research and development biotechnology firm headquartered in Germany, has reported its carbon emissions for several years. In 2025, the company's total emissions were approximately 711,637,000 kg CO2e. This included Scope 1 emissions of around 2,209,000 kg CO2e and Scope 2 emissions of approximately 5,794,000 kg CO2e. Scope 3 emissions accounted for the vast majority, totalling approximately 703,634,000 kg CO2e.
For 2024, BioNTech's total emissions were approximately 892,897,000 kg CO2e, comprising Scope 1 emissions of about 2,415,000 kg CO2e and Scope 2 emissions of around 4,034,000 kg CO2e. Scope 3 emissions for this year were approximately 886,448,000 kg CO2e.
In 2023, total emissions were approximately 534,182,000 kg CO2e, with Scope 1 emissions at about 1,342,000 kg CO2e and Scope 2 emissions at around 3,339,000 kg CO2e. Scope 3 emissions were approximately 529,501,000 kg CO2e.
The company reported a significant reduction in total emissions from 2022 to 2023. In 2022, total emissions were approximately 1,120,551,000 kg CO2e, with Scope 1 emissions at around 866,000 kg CO2e and Scope 2 emissions at approximately 3,162,000 kg CO2e. Scope 3 emissions in 2022 were approximately 1,116,523,000 kg CO2e.
In 2021, total emissions were approximately 1,120,551,000 kg CO2e, with Scope 1 emissions of about 886,000 kg CO2e and Scope 2 emissions of approximately 2,337,000 kg CO2e.
BioNTech has committed to reducing its absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using a 2021 baseline year. This target is aligned with Science Based Targets initiative (SBTi) requirements for near-term goals. Furthermore, the company aims for 72% of its suppliers, covering purchased goods and services, capital goods, and upstream transportation and distribution, to have science-based targets by 2027.
It's important to note that for all reported years, BioNTech has indicated missing data points for certain Scope 3 categories, including purchased goods and services, business travel, and employee commute.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Biontech’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Biontech yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Biontech
Frequently asked questions
Common questions about Biontech’s sustainability data and climate commitments
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project